Thomas Kromann Lund, Christian Holdflod Møller, Jesper Rømhild Davidsen, Hans Henrik Lawaetz Schultz, Pia Bredahl, Jesper Ravn, Peter Skov Olsen, Elisabeth Bendstrup & Michael Perch:
The first 25 years of lung transplantations in Denmark
Ugeskr Læger 2019;181:V09180624
Lung transplantation (LTx) has been performed in Denmark since 1992, and chronic obstructive pulmonary disease and interstitial lung diseases are the major indications. All candidates are subject to an intensive evaluation before being accepted for LTx. Follow-up after transplantation is life-long and includes immunosuppressive medication with a high risk of side effects. The median survival in Denmark
is 7.0 years. Chronic rejection is common, diagnosed by declining lung function, and it is the most important factor for morbidity and mortality. LTx requires dedicated personnel in an interdisciplinary organisation.